CA2194561A1 - Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents - Google Patents

Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents

Info

Publication number
CA2194561A1
CA2194561A1 CA002194561A CA2194561A CA2194561A1 CA 2194561 A1 CA2194561 A1 CA 2194561A1 CA 002194561 A CA002194561 A CA 002194561A CA 2194561 A CA2194561 A CA 2194561A CA 2194561 A1 CA2194561 A1 CA 2194561A1
Authority
CA
Canada
Prior art keywords
mmol
group
radical
solution
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002194561A
Other languages
English (en)
French (fr)
Inventor
Johannes Platzek
Bernd Raduchel
Wolfgang Kramp
Ludger Dinkelborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2194561A1 publication Critical patent/CA2194561A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002194561A 1994-07-14 1995-06-22 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents Abandoned CA2194561A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4425781.3 1994-07-14
DE4425781A DE4425781A1 (de) 1994-07-14 1994-07-14 Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel

Publications (1)

Publication Number Publication Date
CA2194561A1 true CA2194561A1 (en) 1996-02-01

Family

ID=6523740

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194561A Abandoned CA2194561A1 (en) 1994-07-14 1995-06-22 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents

Country Status (11)

Country Link
EP (1) EP0770063A1 (de)
JP (1) JPH10502648A (de)
KR (1) KR970704682A (de)
CN (1) CN1152914A (de)
AU (1) AU698824B2 (de)
CA (1) CA2194561A1 (de)
DE (1) DE4425781A1 (de)
HU (1) HUT76806A (de)
NO (1) NO970140L (de)
WO (1) WO1996002500A1 (de)
ZA (1) ZA955896B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
WO2002004412A2 (en) * 2000-07-06 2002-01-17 Array Biopharma Inc. Tyrosine derivatives as phosphatase inhibitors
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
DK2258401T3 (da) * 2002-05-06 2014-10-13 Endocyte Inc Folat-receptor targetede billeddannelsesmidler

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980147A (en) * 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
DE3762624D1 (de) * 1986-05-28 1990-06-13 Mallinckrodt Inc Technetiumchelate fuer die bestimmung der nierenfunktion.

Also Published As

Publication number Publication date
KR970704682A (ko) 1997-09-06
HUT76806A (en) 1997-11-28
WO1996002500A1 (de) 1996-02-01
AU698824B2 (en) 1998-11-05
JPH10502648A (ja) 1998-03-10
NO970140D0 (no) 1997-01-13
DE4425781A1 (de) 1996-01-18
NO970140L (no) 1997-03-13
EP0770063A1 (de) 1997-05-02
ZA955896B (en) 1996-02-19
CN1152914A (zh) 1997-06-25
AU2886595A (en) 1996-02-16

Similar Documents

Publication Publication Date Title
US4897255A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5037630A (en) Metal radionuclide labeled proteins for diagnosis and therapy
JPH0662555B2 (ja) 放射性核種金属キレート用化合物
US5218128A (en) Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
AU691806B2 (en) Chelating agents of the type XN1S1O1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
US5120526A (en) Method of producing metal radionuclide labeled proteins for diagnosis and therapy
CA2232340A1 (en) Bifunctional nicotinamide-chelating agents such as n2s2 for radioactive isotopes
CA2232391A1 (en) Bifunctional sulfide-containing sulfonamide-chelating agents such as xsns for radioactive isotypes
CA2156618A1 (en) Bifunctional chelators and their use in radiopharmaceuticals
US6488909B1 (en) Chelating agents as well as their tricarbonyl complexes with technetium and rhenium
CA2194561A1 (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents
CA2232315A1 (en) Bifunctional sulfide-containing sulfonamide-chelating agents such as s2 ny for radioactive isotopes
IE920761A1 (en) Chelates, their metal complexes as well as their use in¹diagnosis and treatment
AU692154B2 (en) Chelators of type XN1S1X' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
CA2062483A1 (en) Chelates, their metal complexes as well as their use in diagnosis and treatment
US6143275A (en) Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
CA3201655A1 (en) Radiolabeled compounds targeting the prostate-specific membrane antigen
US5858327A (en) Hydrazino-type N2 S2 radionuclide chelating compounds
WO1997047329A9 (en) Radiopharmaceutical compositions capable of localizing at sites of thrombus
CA2232620A1 (en) Bifunctional sulfide-containing sulfonamide-chelating agents such as xsny for radioactive isotopes
KR100567001B1 (ko) 시스테인 유도체 및 이를 이용한 금속 트리카보닐 착화물,이들의 제조 방법 및 이들을 포함하는 조영제
WO2003044031A1 (en) Technetium or rhenium complexes, radiopharmaceutical products comprising them
JP2005509686A6 (ja) テクネチウム及びレニウム錯体類、それらを含んで成る放射性医薬製品
WO1996007629A1 (en) Technetium chelates to be used for determining the renal function

Legal Events

Date Code Title Description
FZDE Dead